Study to Evaluate the Safety and Efficacy of Selonsertib, Firsocostat, Cilofexor, and Combinations in Participants With Bridging Fibrosis or Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)
Clinical trial NCT03449446 · COMPLETED
Trial details
- NCT number
- NCT03449446
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-21
- Primary completion
- 2019-10-30
- Enrollment
- 395
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.